BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

A MUST ATTEND For Executives in: Portfolio Management, Project Management, 
Strategic Planning, Drug Discovery R&D and Knowledge Management

 Second Annual
 R&D Strategies:
 Managing Risk to Increase R&D Productivity
 May 17-18, 2004
 Philadelphia, PA


 Register Today

 Download Brochure

 Plenary Keynotes:

Robert R. Ruffolo, Ph.D.,
President, Research & Development,
Wyeth Pharmaceuticals;
Senior Vice President,
Wyeth Corporation
Jan-Anders Karlsson, Ph.D.
Executive Vice President,
Pharma Research,
Bayer Healthcare AG

Gianni Gromo M.D.,
Head of Discovery Research

Basel, F. Hoffmann-La Roche Ltd.

 Topics to be Covered:
  • Creating an R&D Model That
    Best Positions
  • Your Organization to Increase
    Profitability
  • Implementing Strategies to Improve
  • Quality of Your Validated Targets
  • Going Beyond Scenario-Based
    Planning into Predictive Mode
  • Profiting from Discovery and
    Marketing Collaboration
  • Increasing an Individual Scientist's
    Productivity
     

     

  Corporate Sponsors:

 

  
 
  


 
 

  Lead Sponsoring Publications:

   

  

  


 R&D Strategies is One of the Five Conferences
 at CHI's The World Pharmaceutical Congress- ID3
 The Other Four Parts of The Congress are:

 ADME/Tox: From A to T

 Cheminformatics: Data Driving Decisions

 Cell-based Assays for HTS

 Hit-to-Lead:Streamlining Lead Generation

SPECIAL FDA PRESENTATION

 Orphan Drug Designation to Encourage Innovation
 Bradley Glasscock, Pharm.D., Office of Orphan Products Development,
 Food & Drug Administration

Strategic View of Risk Assessment

 R&D Productivity Enhancement Through Focus on Drugable Targets: 
 How to Differentiate ?
 
Daniel Schirlin, Ph.D., Head of Global Lead Generation, Aventis

 The Future of Research Productivity and Innovation 
 
Mark Seidler, Ph.D., Senior Engagement Manager,
 Strategic Decisions Group

 
 Strategy, Portfolio Management & Risk

 
Integrated Approach  to Portfolio Management: Linking Discovery  to
 the Market through Clinical Development
 Rick Bayney, Ph.D., Vice President, Portfolio Management, PRD,
 Johnson & Johnson

 Integrated  R&D/Commercial Cross-Functional Approaches 
 to Strategy, Portfolio and Risk
 Ramana Sonty, Senior Director/Team Leader, World Wide
 Development, Pfizer Global Pharmaceuticals

 R&D Strategy and
 Knowledge Management

 Implementing Strategies to Improve the Quality of
 Your Validated Targets

 Douglas Axelrod, Ph.D., R&D Manager, Discovery and Early
 Development, Proctor & Gamble

 
Improving collaboration and decision  making through
 Knowledge Management
 
Harvey L. Wiener, Ph.D., M.B.A., Associate Director,
 Knowledge Integration Resources, Bristol-Myers Squibb Company

 Managing Knowledge for the Business of Science
 
Joseph A. Cerro, Head of Informatics Research,
 Bayer Pharmaceuticals Corporation

 Interactive Panel

 

Innovator or Fast Follower? Creating a Model that Best
Positions Your Organization to Increase Profitability

Panelists:
Gianni Gromo, M.D., Ph.D. , Head of Discovery Research Basel,
F. Hoffmann-La Roche Ltd.
James Resch, Ph.D., Director, Strategic Planning, Drug Discovery,
AstraZeneca
Daniel Schirlin, Ph.D., Head of Global Lead Generation, Aventis
Ramana Sonty, Senior Director/Team Leader  World Wide Development,
Pfizer Global Pharmaceuticals

 Creating A Productive R&D Organization 

 The Unconventional Mindset: A Case Study in Mitigating
 R&D 'Decision Risk'

 Thomas Unger, Ph.D., Vice President - Life Sciences, Wood Mackenzie

 Creating an Organizational Culture That Breeds Productivity
 Kevin Koch, Ph.D., President and Chief Scientific Officer, Array BioPharma


 Creating Drug Hunters: Increasing an Individual Scientist's Productivity
 Andrew Hopkins, Ph.D., Senior Principal Scientist, Molecular Informatics,
 Pfizer Global Research and Development

 R&D Fiscal Responsibility
 A Challenging Strategy: Going Beyond Scenario-based Planning
  into Predictive Mode
 James Resch, Ph.D., Director, Strategic Planning, Drug Discovery,
 AstraZeneca


 Profiting from Discovery and Marketing Collaboration
 
Matthew Bell, Ph.D., Director, Discovery Research Strategy,
 Wyeth Pharmaceuticals

 
Evaluating Outsourcing Options in Drug Discovery - Balancing R&D
 Opportunities with External Partnerships
 
Ron Newbold, Ph.D., Senior Director, Strategic Research Initiatives,
 External Scientific Affairs, Merck & Co

 For More Information on this Event Visit:
 www.chi-intelligentdrug.com


 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.